Members |
targetComponentId |
Picornavirus |
Family Picornaviridae (organism) |
protein i fågelavföring |
Pigeon droppings |
pigmenterat nevus |
Pigmented nevus |
pigmenterad hudlesion av misstänkt malign typ |
Suspected malignant pigmented skin lesion (situation) |
pilokarpinhydroklorid 10 %, ögondroppar |
Product containing precisely pilocarpine hydrochloride 100 milligram/1 milliliter conventional release eye solution (clinical drug) |
Pilocarpine hydrochloride 5.0mg tablet |
Product containing precisely pilocarpine hydrochloride 5 milligram/1 each conventional release oral tablet (clinical drug) |
pilokarpinnitrat 1 %, ögondroppar |
Product containing only pilocarpine in ocular dose form (medicinal product form) |
pilokarpinnitrat 1 %, ögondroppar för engångsbruk |
Product containing only pilocarpine in ocular dose form (medicinal product form) |
pilokarpinnitrat 2 %, ögondroppar |
Product containing only pilocarpine in ocular dose form (medicinal product form) |
pilokarpinnitrat 2 %, ögondroppar för engångsbruk |
Product containing only pilocarpine in ocular dose form (medicinal product form) |
pilokarpinnitrat 4 %, ögondroppar |
Product containing only pilocarpine in ocular dose form (medicinal product form) |
pilokarpinnitrat 4 %, ögondroppar för engångsbruk |
Product containing only pilocarpine in ocular dose form (medicinal product form) |
Pilocarpine nitrate 4% single-use eye drops |
Product containing only pilocarpine in ocular dose form (medicinal product form) |
Pilocytic astrocytoma |
Pilocytic astrocytoma |
Pilonidal cyst with no abscess |
Pilonidal cyst |
rosa färg |
Pink color (qualifier value) |
pioglitazon 15 mg + metformin 1 g, tablett med modifierad frisättning |
Metformin and pioglitazone only product in oral dose form |
pioglitazon 15 mg + metformin 1 g, depåtablett |
Metformin and pioglitazone only product in oral dose form |
pioglitazon 30 mg + metformin 1 g, tablett med modifierad frisättning |
Metformin and pioglitazone only product in oral dose form |
pioglitazon 30 mg + metformin 1 g, depåtablett |
Metformin and pioglitazone only product in oral dose form |
piperacillin 1 g, pulver till injektionsvätska, flaska |
Product containing precisely piperacillin anhydrous (as piperacillin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
piperacillin 2 g, pulver till injektionsvätska, flaska |
Piperacillin anhydrous (as piperacillin sodium) 2 g powder for solution for injection vial |
Piperacillin 3g injection (pdr for recon) |
Piperacillin anhydrous (as piperacillin sodium) 3 g powder for solution for injection vial |
Piperacillin 4g infusion set |
Piperacillin anhydrous (as piperacillin sodium) 4 g powder for solution for injection vial |
piperacillin 4 g, pulver till injektionsvätska, flaska |
Piperacillin anhydrous (as piperacillin sodium) 4 g powder for solution for injection vial |
piperacillin 4 g och tazobaktam 500 mg, pulver och vätska till infusionsvätska, flaska |
Product containing precisely piperacillin (as piperacillin sodium) 4 gram and tazobactam (as tazobactam sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Piperacillin sodium + tazobactam sodium ns/ns injection |
Product containing piperacillin and tazobactam (medicinal product) |
piperacillinnatrium 3 g, pulver till injektionsvätska, flaska |
Piperacillin anhydrous (as piperacillin sodium) 3 g powder for solution for injection vial |
Piperacillin sodium 4g powder for injection solution vial |
Piperacillin anhydrous (as piperacillin sodium) 4 g powder for solution for injection vial |
piperazin 4 g + sennosider 15,3 mg per dospåse, oralt pulver |
Product containing only piperazine and sennoside (medicinal product) |
biverkning av piperidolathydroklorid |
Adverse reaction to piperidolate (disorder) |
Piple cumanesis cumanesis |
Aburria cumanensis subspecies cumanensis (organism) |
pirbuterolacetat 0,2 mg, aerosol |
Product containing only pirbuterol (medicinal product) |
Piringers lymfadenit |
Lymphadenitis caused by Toxoplasma gondii (disorder) |
Piringer-Kuchinskas syndrom |
Lymphadenitis caused by Toxoplasma gondii (disorder) |
Piringer-Kuchinka's syndrome |
Lymphadenitis caused by Toxoplasma gondii (disorder) |
piroxikam 10 mg, dispergerbar tablett |
Piroxicam 10 mg oral tablet |
piroxikam 20 mg, munsönderfallande tablett |
Piroxicam 20 mg oral tablet |
piroxikam 20 mg, dispergerbar tablett |
Piroxicam 20 mg oral tablet |
piroxikam 20 mg, smälttablett |
Piroxicam 20 mg oral tablet |
Pitt Hopkins-liknande syndrom |
CNTNAP2-related developmental and epileptic encephalopathy |
hypofysadenom |
Benign pituitary adenoma (morphologic abnormality) |
Pituitary hypothyroidism |
Secondary hypothyroidism |
Pituitary interstitial cell stimulating hormone |
Pituitary luteinizing hormone |
Pityriasis lichenoides chronica |
Chronic lichenoid pityriasis |
Pityriasis lichenoides et varioliformis acuta |
Acute lichenoid pityriasis |
Pityriasis lichenoides et varioliformis of Mucha-Habermann |
Acute lichenoid pityriasis |
Pityrosporum folliculitis |
Malassezia folliculitis (disorder) |
Pityrosporum infection of skin |
Malassezia infection of skin (disorder) |
pizotylin 250 mikrogram/5 ml, elixir |
Product containing precisely pizotifen 50 microgram/1 milliliter conventional release oral solution (clinical drug) |
Placement |
Insertion - action (qualifier value) |
Placement of prosthesis in organ NOC |
Implantation procedure (procedure) |
Placement of prosthesis in organ NOC NOS |
Implantation procedure (procedure) |
Placement of prosthesis in organ NOC OS |
Implantation procedure (procedure) |
normalstor placenta |
Placental volume within reference range |
avvikande placenta, ante partum |
Placental finding |
placentapolyp, barnet framfött med postnatal komplikation |
Placental polyp with postnatal complication |
onormalt resultat från slätröntgen av revben |
Plain X-ray of bone structure of rib abnormal (finding) |
normalt resultat från slätröntgen av revben |
Plain X-ray of bone structure of rib normal |
Planococcus okeanokoites |
Planomicrobium okeanokoites (organism) |
Plant fiber |
Plant fiber |
Plasma cell leukemia |
Plasma cell leukemia |
plasmacellsmyelom, kategori |
Plasma cell myeloma |
Plasma factor V level |
Clotting factor V assay |
Plasma factor V level |
Clotting factor V assay |
Plasma kallikrein |
Kallikrein |
plasmaproteinfraktion |
Plasma protein fraction (product) |
plasmocytom, kategori |
Plasmacytoma |
Plasmin activator |
Plasminogen activator |
Plasminogen activator |
Plasminogen activator |
Plasminogen inactivator |
Plasminogen activator inhibitor |
Plastic repair of cranium NOS |
Reconstruction of cranial defect |
Plastic repair of cranium NOS |
Reconstruction of cranial defect |
Plastic repair of organ NOC |
Surgical repair |
Platelet precursor |
Megakaryocytic cell |
trombocytsatellit |
Platelet satellite |
von Willebrands sjukdom av trombocyttyp |
Pseudo von Willebrand disease |
Play psychotherapy |
Play therapy |
Pleura endoscopy |
Thoracoscopy |
utgjutning i lungsäck i samband med pankreatit |
Pleural effusion due to pancreatitis (disorder) |
plommon, livsmedel |
Plum (substance) |
Pneumoconiosis due to silicates |
Pneumoconiosis caused by silicate (disorder) |
Pneumocystis carinii DNA |
Pneumocystis jirovecii DNA |
analys avseende Pneumocystis carinii-DNA |
Pneumocystis jirovecii deoxyribonucleic acid assay (procedure) |
Pneumocystis carinii IF |
Pneumocystis jirovecii immunofluorescence (procedure) |
Pneumocystis carinii IF |
Pneumocystis jirovecii immunofluorescence (procedure) |
antigen från Pneumocystis carinii |
Pneumocystis jirovecii antigen |
Pneumocystis carinii antigen assay |
Pneumocystis jirovecii antigen assay (procedure) |
Pneumocystis carinii antigen level |
Pneumocystis jirovecii antigen assay (procedure) |
Pneumocystis carinii antigen level |
Pneumocystis jirovecii antigen assay (procedure) |
Pneumocystis carinii antigen level |
Pneumocystis jirovecii antigen assay (procedure) |
koroidit orsakad av pneumocystis carinii |
Pneumocystis jirovecii choroiditis |
immunfluorescensanalys avseende Pneumocystis carinii |
Pneumocystis jirovecii immunofluorescence (procedure) |
Podophyllin 10% |
Podophyllum resin (substance) |
Podophyllin 20% |
Podophyllum resin (substance) |
Podophyllin 40% |
Podophyllum resin (substance) |
Poephila castanotis |
Taeniopygia guttata (organism) |
Poephila gouldiae |
Chloebia gouldiae (organism) |
Poikilotherm |
Kingdom Animalia (organism) |
Poikilovirus |
Suid herpesvirus 1 |
Poison mushroom |
Order Agaricales |